Volume 9, Issue 3 (7-2011)                   IJRM 2011, 9(3): 223-0 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hemati T, Moghadami-Tabrizi N, Davari-Tanha F, Salmanian B, Javadian P. High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome. IJRM. 2011; 9 (3) :223-0
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-231-en.html
1- Department of Obstetrics and Gynecology, Mirza Kouchak Khan Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Obstetrics and Gynecology, Mirza Kouchak Khan Hospital, Tehran University of Medical Sciences, Tehran, Iran , fatedavari@yahoo.com
3- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (538 Views)
Background: Polycystic ovarian syndrome (PCOS) is a common disease among women in fertility ages and cause severe insulin resistance. Hyperhomocysteinaemia is said to be among the features of PCOS that could influence its outcome.
Objective: This study aimed to investigate whether hyperhomocysteinaemia exists in PCOS and if it is related to insulin resistance in the affected patients.
Materials and Methods: This prospective study was carried out in a university based fertility clinic. Sixty four PCOS patients and 50 normo ovulatory controls were reviewed for fasting glucose, insulin, homocysteine, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) plasma levels in the blood sample of the 3rd day of their menstrual cycle. Insulin resistance was determined with the fasting glucose (mmol/L) to insulin (mIU/L) ratio and HOMA-IR (Homeostasis model assessment-Insulin resistance). Independent-samples T-test and linear regression test were utilized to analyze the obtained data.
Results: Homocysteine levels compared between PCOS patients and control group showed a significant difference. PCOS group was divided into insulin resistant (IR) (LogHOMA-IR?0.57) and non insulin resistant (NIR) patients. The IR group had significantly higher homocysteine (p-value=0.02), fasting insulin and glucose levels (p-value<0.001) rather than NIR group.
Conclusion: PCOS patients have a leaning toward hyperhomocysteinaemia and insulin resistance. Insulin resistant patients are found to have higher homocysteine level.
Full-Text [PDF 323 kb]   (80 Downloads) |   |   Full-Text (HTML)  (17 Views)  
Type of Study: Original Article |

1. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800. [DOI:10.1210/er.18.6.774]
2. Gennarelli G, Holte J, Berglund L, Berne C, Massobrio M, Lithell H. Prediction models for insulin resistance in the polycystic ovary syndrome. Hum Reprod 2000; 15: 2098-2102. [DOI:10.1093/humrep/15.10.2098]
3. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 2003; 18: 721-727. [DOI:10.1093/humrep/deg190]
4. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 1995; 15: 821-826. [DOI:10.1161/01.ATV.15.7.821]
5. Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A, et al. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf) 1996; 44: 277-284. [DOI:10.1046/j.1365-2265.1996.674495.x]
6. Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab 1998; 83: 550-553. [DOI:10.1210/jcem.83.2.4574]
7. McCarty MF. Increased homocysteine associated with smoking, chronic inflammation, and aging may reflect acute-phase induction of pyridoxal phosphatase activity. Med Hypotheses 2000; 55: 289-293. [DOI:10.1054/mehy.1999.1032]
8. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998; 67: 263-270. [DOI:10.1093/ajcn/67.2.263]
9. House JD, Jacobs RL, Stead LM, Brosnan ME, Brosnan JT. Regulation of homocysteine metabolism. Adv Enzyme Regul 1999; 39: 69-91. [DOI:10.1016/S0065-2571(98)00008-9]
10. McCarty MF. Insulin secretion as a potential determinant of homocysteine levels. Med Hypotheses 2000; 55: 454-455. [DOI:10.1054/mehy.1999.1008]
11. Bar-On H, Kidron M, Friedlander Y, Ben-Yehuda A, Selhub J, Rosenberg IH, et al. Plasma total homocysteine levels in subjects with hyper insulinemia. J Intern Med 2000; 247: 287-294. [DOI:10.1046/j.1365-2796.2000.00592.x]
12. Karaer A, Cavkaytar S, Mert I, Buyukkagnici U, Batioglu S. Cardiovascular risk factors in polycystic ovary syndrome. J Obstet Gynaecol 2010; 30: 387-392. [DOI:10.3109/01443611003763408]
13. Mohamadin AM, Habib FA, Al-Saggaf AA. Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine. Ann Saudi Med 2010; 30: 278-283. [DOI:10.4103/0256-4947.65255]
14. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006; 113: 1210-1217. [DOI:10.1111/j.1471-0528.2006.01008.x]
15. Quon MJ. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab 2001; 86: 4615-4617. [DOI:10.1210/jcem.86.10.7952]
16. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495. [DOI:10.2337/diacare.27.6.1487]
17. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al; Framingham Offspring Study. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001; 24: 1403-1410. [DOI:10.2337/diacare.24.8.1403]
18. Laivuori H, Kaaja R, Turpeinen U, Viinikka L, Ylikorkala O. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol 1999; 93: 489-493.
19. Badawy A, State O, El Gawad SSh, El Aziz OA. Plasma homocysteine and polycystic ovary syndrome: the missed link. Eur J Obstet Gynecol Reprod Biol 2007; 131: 68-72. [DOI:10.1016/j.ejogrb.2006.10.015]
20. Bayraktar F, Dereli D, Ozgen AG, Yilmaz C. Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia. Endocr J 2004; 51: 601-608. [DOI:10.1507/endocrj.51.601]
21. Sills ES, Genton MG, Perloe M, Schattman GL, Bralley JA, Tucker MJ. Plasma homocysteine, fasting insulin, and androgen patterns among women with polycystic ovaries and infertility. J Obstet Gynaecol Res 2001; 27: 163-168. [DOI:10.1111/j.1447-0756.2001.tb01241.x]
22. Kilic-Okman T, Guldiken S, Kucuk M. Relationship between homocysteine and insulin resistance in women with polycystic ovary syndrome. Endocr J 2004; 51: 505-508. [DOI:10.1507/endocrj.51.505]
23. Rosolová H, Simon J, Mayer O Jr, Racek J, Dierzé T, Jacobsen DW. Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects. Physiol Res 2002; 51: 93-98.
24. Goldstein BJ, Haffner SM, Hsueh WA. Insulin resistance implications for metabolic and cardiovascular diseases. CME Circle Diabetes and Endocrinology continuing medical education online: http://www.medscape.org/ viewarticle/412860. 2001.

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb